MIR9-2HG and breast cancer: LINC00461 has a cancer-promoting effect in a variety of tumors, including colorectal cancer [16], breast cancer [17], lung cancer [18], gastric cancer [19], and so on, and in vitro experiments confirm that LINC00461 can promote tumor cell proliferation, migration, invasion, or inhibit apoptosis.